KinderCare Learning KLC Q1 2026 Earnings Strong EPS Beat Despite Revenue Discretion UROY Q1 2026 Earnings Surprise Profit Amid Modest Market Reaction Hubbell Q1 2026 Earnings Slight EPS Miss Fails to Dampen Investor Sentiment as Core Segments Hold Steady Lyell Immunopharma Q1 2026 Earnings Narrower Loss Surprises Expectations Amid Clinical Progress CFR Q1 2026 Earnings Solid EPS Beat Amid Stable Performance ADAML Q1 2026 Earnings Preferred EPS Crushes Estimates by 75 as FixedtoFloating Rate Structure Gains Traction